Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc., trading under the ticker LACQ, filed a Form 10-Q with the Securities and Exchange Commission on November 7, 2018, reporting quarterly financial results during its tenure as a blank check company. LACQ completed its initial public offering in 2018 and pursued acquisition targets within the healthcare and biosciences sector. The filing, recorded under accession number 0001615774-18-012252, represents a routine periodic disclosure made while the SPAC was in its active search phase. Sponsor details, deal-tracking analytics, and the full regulatory filing history for LACQ are available to registered users on SpacDesk — sign up today for complete access.